Varicella Virus Vaccine Manufacturer
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract through the Department of Defense Medical Supply Chain Pharm FSA requires a manufacturer to provide live, lyophilized Varicella Virus Vaccine and corresponding diluents. The manufacturer must possess the necessary lyophilization equipment and FDA approval to produce the vaccine, ensuring a total shelf life of 18 months. Each delivery unit consists of one package containing 10 vaccine vials and 10 diluent vials. All packaging and labeling must strictly adhere to MIL-STD-2073-1E and Medical Marking Standard No. 1B. The place of performance for this contract is located in Niagara Falls, New York. Interested parties should note the response deadline of November 12, 2026, for this pharmaceutical supply requirement under NAICS code 325412.
General Info
Place of Performance
NIAGARA FALLS, NY, 14304-5022, USASet-Aside
Documents
This scope was carved out of SPE2DP-27-T-0248.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
VARICELLA VIRUS VACCIN
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
